Spruce Biosciences Inc expected to post a loss of 53 cents a share - Earnings Preview

Spruce Biosciences

10/03/2023 11:42

* Spruce Biosciences Inc  SPRB.OQ   SPRB.O  is expected
to show no
change in quarterly revenue when it reports  results on March 13
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Spruce Biosciences
Inc is
for a loss of 53 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Spruce
Biosciences Inc is $8​, above​ its last closing price of $2.38.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.54       -0.53      -0.48     Beat    10.3
 Jun. 30 2022  -0.53       -0.52      -0.51     Beat    2.9
 Mar. 31 2022  -0.46       -0.46      -0.50     Missed  -9.1​
 Dec. 31 2021  -0.54       -0.54      -0.39     Beat    27.8
 ​​Sep.        -0.58       -0.57      -0.49     Beat    14.4
 30 2021                                                
 Jun. 30 2021  -0.45       -0.45      -0.50     Missed  -11.1​
 Mar. 31 2021  -0.42       -0.42      -0.42     Met     0.8
 Dec. 31 2020              -0.59      -0.39     Beat    34.4
 This summary was machine generated March 10 at 11:42 GMT.  All
figures in US dollars  unless otherwise stated